5N53 | Oxidoreductase | date | Feb 12, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human 3-Phosphoglycerate Dehydrogenase With N-(3-Chloro-4-Methoxyphenyl) Acetamide | ||||||||||||||
authors | J.E.Unterlass, A.Basle, T.J.Blackburn, J.Tucker, C.Cano, M.E.M.No N.J.Curtin | ||||||||||||||
compound | source | ||||||||||||||
Molecule: D-3-Phosphoglycerate Dehydrogenase Chain: B, A Synonym: 3-Pgdh Ec: 1.1.1.95 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Phgdh, Pgdh3 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_variant: Rosetta (De3) | ||||||||||||||
symmetry | Space Group: P 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.48 Å | ||||||||||||
ligand | 8NB | enzyme | Oxidoreductase E.C.1.1.1.95 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer., Unterlass JE, Basle A, Blackburn TJ, Tucker J, Cano C, Noble MEM, Curtin NJ, Oncotarget. 2016 Aug 22;9(17):13139-13153. doi: 10.18632/oncotarget.11487., eCollection 2018 Mar 2. PMID:29568346 |
Data retrieval |
View 5N53 in 3D |
Visual 3D analysis of 5N53 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5N53 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |